Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin.
about
Rapid and sensitive determination of levofloxacin in microsamples of human plasma by high-performance liquid chromatography and its application in a pharmacokinetic study.Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluationCorrelation between octanol/water and liposome/water distribution coefficients and drug absorption of a set of pharmacologically active compounds.Formulation and Evaluation of New Glimepiride Sublingual Tablets.Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.Analysis of multi-site drug-protein interactions by high-performance affinity chromatography: Binding by glimepiride to normal or glycated human serum albuminThe influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans.Population pharmacokinetic analysis of glimepiride with CYP2C9 genetic polymorphism in healthy Korean subjects.A controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilm.Characterization of the absorption of theophylline from immediate- and controlled-release dosage forms with a numerical approach using the in vitro dissolution-permeation process using caco-2 cells.Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans.Modification of graphene oxide by a facile coprecipitation method and click chemistry for use as a drug carrier
P2860
Q35193051-496C1AA1-55F3-4D99-A38B-DF9DB8A72221Q36442159-3AD3FC49-DF93-41FE-BD0D-8B770C5A40ECQ38086939-1EDFB7E1-E51A-4AE3-90E8-CD1689619219Q39201051-B16CB1C9-5110-49E6-AACE-E805B6343420Q40225657-FFB8E222-4E5A-47F2-BF81-9DDB42B90E56Q40246531-6C071683-203B-497D-904C-DFB3F26377B4Q41831692-2DEFFED3-3B7C-4332-8FF3-3B220DD51A92Q43985265-8911AC52-ACE6-4748-BD8F-AC63E99DF68DQ44881633-1D7F186C-7E9D-4A32-B64F-C890AAFEE399Q45173405-5D02ACAC-B66C-4641-B57B-A0B81D458D4CQ46171827-49651E19-89F7-4E4C-B289-B8F46BC81641Q53589134-1BBAA740-9575-4E8E-9D8A-6DFE354074A3Q57365507-628E58C6-7827-4D71-A375-24984FD67789
P2860
Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Biopharmaceutical characteriza ...... glimepiride and levofloxacin.
@en
type
label
Biopharmaceutical characteriza ...... glimepiride and levofloxacin.
@en
prefLabel
Biopharmaceutical characteriza ...... glimepiride and levofloxacin.
@en
P2093
P1476
Biopharmaceutical characteriza ...... glimepiride and levofloxacin.
@en
P2093
P304
P356
10.1016/S0939-6411(98)00041-1
P407
P577
1998-11-01T00:00:00Z